0 XP   0   0   0

Deva Holding AS
Buy, Hold or Sell?

Should you buy, hold or sell Deva?

I guess you are interested in Deva Holding AS. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Deva

Let's start. I'm going to help you getting a better view of Deva Holding AS. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Deva Holding AS even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Deva Holding AS is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Deva Holding AS. The closing price on 2023-03-31 was ₺37.86 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Deva Holding AS Daily Candlestick Chart
Deva Holding AS Daily Candlestick Chart
Summary









1. Valuation of Deva




Current price per share

₺37.86

2. Growth of Deva




Is Deva growing?

Current yearPrevious yearGrowGrow %
How rich?$142.3m$85.3m$57m40.1%

How much money is Deva making?

Current yearPrevious yearGrowGrow %
Making money$61m$34m$27m44.3%
Net Profit Margin50.2%35.0%--

How much money comes from the company's main activities?

3. Financial Health of Deva




Comparing to competitors in the Drug Manufacturers-Specialty & Generic industry




  Industry Rankings (Drug Manufacturers-Specialty & Generic)  


Richest
#325 / 704

Most Revenue
#283 / 704

Most Profit
#100 / 704


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is very efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Deva Holding AS.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Deva earns for each ₤1 of revenue.

  • Above 10% is considered healthy but always compare Deva to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Net Profit Margin of 50.2% means that ₤0.50 for each ₤1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Deva Holding AS:

  • The MRQ is 50.2%. The company is making a huge profit. +2
  • The TTM is 50.2%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ50.2%TTM50.2%0.0%
TTM50.2%YOY35.0%+15.2%
TTM50.2%5Y26.1%+24.1%
5Y26.1%10Y16.4%+9.8%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ50.2%1.5%+48.7%
TTM50.2%1.7%+48.5%
YOY35.0%1.8%+33.2%
5Y26.1%0.7%+25.4%
10Y16.4%0.7%+15.7%
1.1.2. Return on Assets

Shows how efficient Deva is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Deva to the Drug Manufacturers-Specialty & Generic industry mean.
  • 23.0% Return on Assets means that Deva generated ₤0.23 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Deva Holding AS:

  • The MRQ is 23.0%. Using its assets, the company is very efficient in making profit. +2
  • The TTM is 23.0%. Using its assets, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ23.0%TTM23.0%0.0%
TTM23.0%YOY21.1%+1.9%
TTM23.0%5Y14.6%+8.4%
5Y14.6%10Y9.3%+5.4%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ23.0%-0.2%+23.2%
TTM23.0%-0.2%+23.2%
YOY21.1%0.2%+20.9%
5Y14.6%0.1%+14.5%
10Y9.3%0.2%+9.1%
1.1.3. Return on Equity

Shows how efficient Deva is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Deva to the Drug Manufacturers-Specialty & Generic industry mean.
  • 42.9% Return on Equity means Deva generated ₤0.43 for each ₤1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Deva Holding AS:

  • The MRQ is 42.9%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 42.9%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ42.9%TTM42.9%0.0%
TTM42.9%YOY39.9%+3.0%
TTM42.9%5Y28.8%+14.1%
5Y28.8%10Y18.4%+10.5%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ42.9%1.5%+41.4%
TTM42.9%1.5%+41.4%
YOY39.9%1.7%+38.2%
5Y28.8%0.5%+28.3%
10Y18.4%0.4%+18.0%

1.2. Operating Efficiency of Deva Holding AS.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Deva is operating .

  • Measures how much profit Deva makes for each ₤1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Deva to the Drug Manufacturers-Specialty & Generic industry mean.
  • An Operating Margin of 36.1% means the company generated ₤0.36  for each ₤1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Deva Holding AS:

  • The MRQ is 36.1%. The company is operating very efficient. +2
  • The TTM is 36.1%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ36.1%TTM36.1%0.0%
TTM36.1%YOY34.0%+2.1%
TTM36.1%5Y28.1%+8.0%
5Y28.1%10Y19.4%+8.7%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ36.1%4.7%+31.4%
TTM36.1%4.7%+31.4%
YOY34.0%4.8%+29.2%
5Y28.1%2.9%+25.2%
10Y19.4%3.2%+16.2%
1.2.2. Operating Ratio

Measures how efficient Deva is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • An Operation Ratio of 1.06 means that the operating costs are ₤1.06 for each ₤1 in net sales.

Let's take a look of the Operating Ratio trends of Deva Holding AS:

  • The MRQ is 1.056. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.056. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.056TTM1.0560.000
TTM1.056YOY1.142-0.086
TTM1.0565Y1.221-0.165
5Y1.22110Y1.161+0.060
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0561.449-0.393
TTM1.0561.452-0.396
YOY1.1421.426-0.284
5Y1.2211.440-0.219
10Y1.1611.332-0.171

1.3. Liquidity of Deva Holding AS.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Deva is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Current Ratio of 2.07 means the company has ₤2.07 in assets for each ₤1 in short-term debts.

Let's take a look of the Current Ratio trends of Deva Holding AS:

  • The MRQ is 2.066. The company is able to pay all its short-term debts. +1
  • The TTM is 2.066. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.066TTM2.0660.000
TTM2.066YOY1.974+0.093
TTM2.0665Y1.805+0.262
5Y1.80510Y1.345+0.459
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0661.915+0.151
TTM2.0661.971+0.095
YOY1.9742.063-0.089
5Y1.8052.415-0.610
10Y1.3452.244-0.899
1.3.2. Quick Ratio

Measures if Deva is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Deva to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Quick Ratio of 0.60 means the company can pay off ₤0.60 for each ₤1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Deva Holding AS:

  • The MRQ is 0.596. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.596. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.596TTM0.5960.000
TTM0.596YOY0.701-0.106
TTM0.5965Y0.762-0.166
5Y0.76210Y0.750+0.012
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5960.849-0.253
TTM0.5960.886-0.290
YOY0.7010.928-0.227
5Y0.7621.052-0.290
10Y0.7501.061-0.311

1.4. Solvency of Deva Holding AS.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Deva assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Deva to Drug Manufacturers-Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.46 means that Deva assets are financed with 46.3% credit (debt) and the remaining percentage (100% - 46.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Deva Holding AS:

  • The MRQ is 0.463. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.463. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.463TTM0.4630.000
TTM0.463YOY0.471-0.008
TTM0.4635Y0.504-0.041
5Y0.50410Y0.509-0.005
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4630.420+0.043
TTM0.4630.420+0.043
YOY0.4710.410+0.061
5Y0.5040.417+0.087
10Y0.5090.427+0.082
1.4.2. Debt to Equity Ratio

Measures if Deva is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Deva to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Debt to Equity ratio of 86.2% means that company has ₤0.86 debt for each ₤1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Deva Holding AS:

  • The MRQ is 0.862. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.862. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.862TTM0.8620.000
TTM0.862YOY0.889-0.027
TTM0.8625Y1.024-0.162
5Y1.02410Y1.043-0.019
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8620.661+0.201
TTM0.8620.661+0.201
YOY0.8890.612+0.277
5Y1.0240.667+0.357
10Y1.0430.685+0.358

2. Market Valuation of Deva Holding AS

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₤1 in earnings Deva generates.

  • Above 15 is considered overpriced but always compare Deva to the Drug Manufacturers-Specialty & Generic industry mean.
  • A PE ratio of 4.91 means the investor is paying ₤4.91 for every ₤1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Deva Holding AS:

  • The EOD is 6.472. Very good. +2
  • The MRQ is 4.913. Very good. +2
  • The TTM is 4.913. Very good. +2
Trends
Current periodCompared to+/- 
EOD6.472MRQ4.913+1.559
MRQ4.913TTM4.9130.000
TTM4.913YOY7.412-2.499
TTM4.9135Y6.581-1.668
5Y6.58110Y13.626-7.045
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD6.472-0.011+6.483
MRQ4.913-0.064+4.977
TTM4.9130.201+4.712
YOY7.4127.254+0.158
5Y6.5816.962-0.381
10Y13.6269.812+3.814
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Deva.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Deva Holding AS:

  • The MRQ is 2.735. Seems overpriced? -1
  • The TTM is 2.735. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ2.735TTM2.7350.000
TTM2.735YOY3.254-0.519
TTM2.7355Y3.687-0.951
5Y3.68710Y20.820-17.134
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ2.7355.722-2.987
TTM2.7356.855-4.120
YOY3.2547.605-4.351
5Y3.68719.720-16.033
10Y20.82029.132-8.312

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Deva is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A PB ratio of 2.11 means the investor is paying ₤2.11 for each ₤1 in book value.

Let's take a look of the Price to Book Ratio trends of Deva Holding AS:

  • The EOD is 2.776. Good. +1
  • The MRQ is 2.107. Good. +1
  • The TTM is 2.107. Good. +1
Trends
Current periodCompared to+/- 
EOD2.776MRQ2.107+0.669
MRQ2.107TTM2.1070.000
TTM2.107YOY2.954-0.847
TTM2.1075Y1.827+0.280
5Y1.82710Y1.526+0.301
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD2.7761.436+1.340
MRQ2.1071.958+0.149
TTM2.1071.988+0.119
YOY2.9542.278+0.676
5Y1.8272.452-0.625
10Y1.5262.968-1.442
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Deva Holding AS compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--5.4665.4660%3.017+81%2.215+147%1.192+359%
Book Value Growth--1.6691.6690%1.585+5%1.410+18%1.247+34%
Book Value Per Share--13.63813.6380%8.171+67%6.744+102%4.452+206%
Book Value Per Share Growth--1.6691.6690%1.585+5%1.410+18%1.247+34%
Current Ratio--2.0662.0660%1.974+5%1.805+15%1.345+54%
Debt To Asset Ratio--0.4630.4630%0.471-2%0.504-8%0.509-9%
Debt To Equity Ratio--0.8620.8620%0.889-3%1.024-16%1.043-17%
Dividend Per Share--0.4930.4930%0.267+85%0.312+58%0.156+216%
Dividend Per Share Growth--1.8491.8490%1.000+85%1.212+53%1.212+53%
Eps--5.8505.8500%3.257+80%2.336+150%1.256+366%
Eps Growth--1.7961.7960%2.278-21%1.836-2%1.887-5%
Free Cash Flow Per Share--3.3333.3330%1.405+137%1.130+195%0.624+434%
Free Cash Flow Per Share Growth--2.3722.3720%1.245+90%2.723-13%2.898-18%
Free Cash Flow To Equity Per Share--4.1894.1890%1.670+151%1.398+200%0.756+454%
Free Cash Flow To Equity Per Share Growth--2.5082.5080%2.270+11%3.122-20%3.367-26%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--117.415--------
Intrinsic Value_10Y_min--97.884--------
Intrinsic Value_1Y_max--5.163--------
Intrinsic Value_1Y_min--5.017--------
Intrinsic Value_3Y_max--20.544--------
Intrinsic Value_3Y_min--19.313--------
Intrinsic Value_5Y_max--41.993--------
Intrinsic Value_5Y_min--38.146--------
Net Profit Margin--0.5020.5020%0.350+44%0.261+92%0.164+207%
Operating Margin--0.3610.3610%0.340+6%0.281+28%0.194+86%
Operating Ratio--1.0561.0560%1.142-8%1.221-14%1.161-9%
Pb Ratio2.776+24%2.1072.1070%2.954-29%1.827+15%1.526+38%
Pe Ratio6.472+24%4.9134.9130%7.412-34%6.581-25%13.626-64%
Peg Ratio--2.7352.7350%3.254-16%3.687-26%20.820-87%
Price Per Share37.860+24%28.74028.7400%24.140+19%13.908+107%8.298+246%
Price To Total Gains Ratio6.353+24%4.8224.8220%7.350-34%5.379-10%13.231-64%
Profit Growth--1.7961.7960%2.278-21%1.836-2%1.887-5%
Quick Ratio--0.5960.5960%0.701-15%0.762-22%0.750-21%
Return On Assets--0.2300.2300%0.211+9%0.146+57%0.093+149%
Return On Equity--0.4290.4290%0.399+8%0.288+49%0.184+134%
Revenue Growth--1.2511.2510%1.356-8%1.278-2%1.197+5%
Total Gains Per Share--5.9605.9600%3.284+81%2.527+136%1.348+342%
Total Gains Per Share Growth--1.8151.8150%1.945-7%1.854-2%1.732+5%
Usd Book Value--142389951.309142389951.3090%85314769.319+67%70412574.642+102%46479122.943+206%
Usd Book Value Change Per Share--0.2850.2850%0.158+81%0.116+147%0.062+359%
Usd Book Value Per Share--0.7120.7120%0.427+67%0.352+102%0.232+206%
Usd Dividend Per Share--0.0260.0260%0.014+85%0.016+58%0.008+216%
Usd Eps--0.3050.3050%0.170+80%0.122+150%0.066+366%
Usd Free Cash Flow--34801859.90334801859.9030%14669997.037+137%11798423.558+195%5899211.779+490%
Usd Free Cash Flow Per Share--0.1740.1740%0.073+137%0.059+195%0.033+434%
Usd Free Cash Flow To Equity Per Share--0.2190.2190%0.087+151%0.073+200%0.039+454%
Usd Price Per Share1.976+24%1.5001.5000%1.260+19%0.726+107%0.433+246%
Usd Profit--61078566.24761078566.2470%34005621.305+80%24392597.435+150%13112715.492+366%
Usd Revenue--121645198.690121645198.6900%97265747.752+25%77346326.807+57%52092099.766+134%
Usd Total Gains Per Share--0.3110.3110%0.171+81%0.132+136%0.070+342%
 EOD+2 -3MRQTTM+0 -0YOY+35 -75Y+32 -1010Y+34 -8

3.2. Fundamental Score

Let's check the fundamental score of Deva Holding AS based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-156.472
Price to Book Ratio (EOD)Between0-12.776
Net Profit Margin (MRQ)Greater than00.502
Operating Margin (MRQ)Greater than00.361
Quick Ratio (MRQ)Greater than10.596
Current Ratio (MRQ)Greater than12.066
Debt to Asset Ratio (MRQ)Less than10.463
Debt to Equity Ratio (MRQ)Less than10.862
Return on Equity (MRQ)Greater than0.150.429
Return on Assets (MRQ)Greater than0.050.230
Total8/10 (80.0%)

3.3. Technical Score

Let's check the technical score of Deva Holding AS based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5028.541
Ma 20Greater thanMa 5043.928
Ma 50Greater thanMa 10046.154
Ma 100Greater thanMa 20051.609
OpenGreater thanClose38.440
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2021-12-31. Currency in TRY. All numbers in thousands.

Summary
Total Assets5,079,932
Total Liabilities2,352,155
Total Stockholder Equity2,727,777
 As reported
Total Liabilities 2,352,155
Total Stockholder Equity+ 2,727,777
Total Assets = 5,079,932

Assets

Total Assets5,079,932
Total Current Assets3,373,445
Long-term Assets3,373,445
Total Current Assets
Cash And Cash Equivalents 1,310,974
Net Receivables 972,337
Inventory 1,049,454
Other Current Assets 23,763
Total Current Assets  (as reported)3,373,445
Total Current Assets  (calculated)3,356,528
+/- 16,916
Long-term Assets
Property Plant Equipment 1,059,750
Goodwill 1,783
Intangible Assets 354,338
Other Assets 536,385
Long-term Assets  (as reported)1,706,487
Long-term Assets  (calculated)1,952,255
+/- 245,767

Liabilities & Shareholders' Equity

Total Current Liabilities1,632,487
Long-term Liabilities719,668
Total Stockholder Equity2,727,777
Total Current Liabilities
Short Long Term Debt 1,107,447
Accounts payable 349,320
Other Current Liabilities 37,523
Total Current Liabilities  (as reported)1,632,487
Total Current Liabilities  (calculated)1,494,291
+/- 138,197
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt170,149
Other Liabilities 99,622
Deferred Long Term Liability 245,767
Long-term Liabilities  (as reported)719,668
Long-term Liabilities  (calculated)515,539
+/- 204,129
Total Stockholder Equity
Common Stock200,019
Retained Earnings 2,362,114
Other Stockholders Equity 162,801
Total Stockholder Equity (as reported)2,727,777
Total Stockholder Equity (calculated)2,724,935
+/- 2,842
Other
Capital Stock200,019
Common Stock Shares Outstanding 200,019
Net Debt 253,057
Net Invested Capital 4,291,808
Net Tangible Assets 2,617,424
Net Working Capital 1,740,957



Balance Sheet

Currency in TRY. All numbers in thousands.

 Trend2021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-31
> Total Assets 
273,183
290,884
385,283
489,794
528,422
622,801
666,253
723,256
826,627
893,532
992,952
1,017,527
1,256,407
1,668,440
2,119,502
3,087,916
5,079,932
5,079,9323,087,9162,119,5021,668,4401,256,4071,017,527992,952893,532826,627723,256666,253622,801528,422489,794385,283290,884273,183
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
412,977
475,767
449,634
621,511
962,287
1,241,271
1,949,038
3,373,445
3,373,4451,949,0381,241,271962,287621,511449,634475,767412,977000000000
       Cash And Cash Equivalents 
6,034
16,429
15,520
6,566
0
466
17,636
16,579
55,450
42,144
36,329
27,476
77,870
121,030
277,046
609,465
1,310,974
1,310,974609,465277,046121,03077,87027,47636,32942,14455,45016,57917,63646606,56615,52016,4296,034
       Short-term Investments 
30
177
0
73
0
0
0
0
0
0
0
0
0
86
269,257
0
0
00269,2578600000000073017730
       Net Receivables 
122,532
108,356
134,304
156,398
165,497
151,645
182,312
205,143
179,958
196,259
240,635
211,534
292,429
404,473
482,520
692,308
972,337
972,337692,308482,520404,473292,429211,534240,635196,259179,958205,143182,312151,645165,497156,398134,304108,356122,532
       Other Current Assets 
8,296
12,500
24,795
4,438
4,197
44,391
9,089
13,977
16,990
19,620
10,351
17,008
13,284
23,642
5,037
7,939
23,763
23,7637,9395,03723,64213,28417,00810,35119,62016,99013,9779,08944,3914,1974,43824,79512,5008,296
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
567,893
634,896
706,153
878,231
1,138,878
1,706,487
1,706,4871,138,878878,231706,153634,896567,89300000000000
       Property Plant Equipment 
83,380
84,872
127,402
185,295
191,695
193,973
229,896
262,222
280,901
298,276
301,195
324,181
364,828
401,535
530,979
766,679
1,059,750
1,059,750766,679530,979401,535364,828324,181301,195298,276280,901262,222229,896193,973191,695185,295127,40284,87283,380
       Goodwill 
0
4,307
0
1,783
1,783
1,783
1,783
1,783
1,783
1,783
1,783
1,783
1,783
1,783
1,783
1,783
1,783
1,7831,7831,7831,7831,7831,7831,7831,7831,7831,7831,7831,7831,7831,78304,3070
       Intangible Assets 
13,494
17,749
6,360
21,212
23,282
54,497
49,516
57,421
64,586
66,415
85,699
218,770
238,512
271,982
297,376
286,445
354,338
354,338286,445297,376271,982238,512218,77085,69966,41564,58657,42149,51654,49723,28221,2126,36017,74913,494
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
567,893
634,896
706,153
878,231
0
0
00878,231706,153634,896567,89300000000000
> Total Liabilities 
158,681
101,433
117,380
234,252
223,271
282,977
321,812
344,627
423,577
481,623
539,840
504,680
651,317
922,032
1,088,660
1,453,533
2,352,155
2,352,1551,453,5331,088,660922,032651,317504,680539,840481,623423,577344,627321,812282,977223,271234,252117,380101,433158,681
   > Total Current Liabilities 
115,102
73,626
100,773
205,848
183,943
229,791
231,416
271,892
221,711
262,839
463,414
245,446
418,736
584,100
670,475
987,420
1,632,487
1,632,487987,420670,475584,100418,736245,446463,414262,839221,711271,892231,416229,791183,943205,848100,77373,626115,102
       Short-term Debt 
0
0
0
0
0
0
0
0
0
41,908
153,788
152,844
296,938
307,212
232,198
0
0
00232,198307,212296,938152,844153,78841,908000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
41,908
153,788
152,844
296,938
307,212
232,198
698,968
1,107,447
1,107,447698,968232,198307,212296,938152,844153,78841,908000000000
       Accounts payable 
24,931
19,708
27,292
58,087
36,033
71,919
34,862
22,964
25,147
31,865
46,654
41,891
62,882
84,421
129,774
166,257
349,320
349,320166,257129,77484,42162,88241,89146,65431,86525,14722,96434,86271,91936,03358,08727,29219,70824,931
       Other Current Liabilities 
12,926
20,006
29,154
34,155
48,300
48,784
41,328
33,993
29,486
32,709
10,570
8,500
17,339
17,527
22,905
20,982
37,523
37,52320,98222,90517,52717,3398,50010,57032,70929,48633,99341,32848,78448,30034,15529,15420,00612,926
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
259,234
232,581
337,932
418,185
466,113
719,668
719,668466,113418,185337,932232,581259,23400000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
-41,908
-153,788
-152,844
-296,938
-307,212
-212,597
71,078
170,149
170,14971,078-212,597-307,212-296,938-152,844-153,788-41,908000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
14,346
20,174
31,756
37,666
46,220
48,176
48,17646,22037,66631,75620,17414,34600000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
88,422
96,961
125,195
124,083
142,965
185,232
187,166
245,767
245,767187,166185,232142,965124,083125,19596,96188,422000000000
> Total Stockholder Equity
114,502
189,451
267,883
255,422
305,011
339,682
344,365
378,552
402,987
411,868
453,111
512,848
605,090
746,408
1,030,842
1,634,383
2,727,777
2,727,7771,634,3831,030,842746,408605,090512,848453,111411,868402,987378,552344,365339,682305,011255,422267,883189,451114,502
   Common Stock
48,000
48,000
48,000
48,000
144,000
180,071
200,000
200,000
200,000
200,000
200,000
200,019
200,019
200,019
200,019
200,019
200,019
200,019200,019200,019200,019200,019200,019200,000200,000200,000200,000200,000180,071144,00048,00048,00048,00048,000
   Retained Earnings 
33,389
0
135,640
0
18,580
16,905
1,296
35,536
60,140
68,863
116,523
176,854
269,396
408,834
692,570
1,290,668
2,362,114
2,362,1141,290,668692,570408,834269,396176,854116,52368,86360,14035,5361,29616,90518,5800135,640033,389
   Capital Surplus 00000000000000000
   Treasury Stock0000-29000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
140,134
133,717
133,132
132,832
134,713
135,411
140,854
162,801
162,801140,854135,411134,713132,832133,132133,717140,134000000000



Balance Sheet

Currency in TRY. All numbers in thousands.




Cash Flow

Currency in TRY. All numbers in thousands.




Income Statement

Currency in TRY. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue2,330,368
Cost of Revenue-971,239
Gross Profit1,359,1291,359,129
 
Operating Income (+$)
Gross Profit1,359,129
Operating Expense-1,489,257
Operating Income841,111-130,128
 
Operating Expense (+$)
Research Development73,966
Selling General Administrative191,356
Selling And Marketing Expenses-
Operating Expense1,489,257265,323
 
Net Interest Income (+$)
Interest Income17,856
Interest Expense-227,913
Net Interest Income-215,780-210,057
 
Pretax Income (+$)
Operating Income841,111
Net Interest Income-215,780
Other Non-Operating Income Expenses-
Income Before Tax (EBT)1,158,328841,111
EBIT - interestExpense = 613,198
1,158,328
1,398,001
Interest Expense227,913
Earnings Before Interest and Taxes (ebit)841,1111,386,241
Earnings Before Interest and Taxes (ebitda)1,465,398
 
After tax Income (+$)
Income Before Tax1,158,328
Tax Provision--11,759
Net Income From Continuing Ops1,170,0871,170,087
Net Income1,170,087
Net Income Applicable To Common Shares1,170,087
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses25,351
Total Other Income/Expenses Net-215,780
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
AXNA.F
2 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of AXNA.F.

AXNA.F Daily Candlestick Chart
AS3.F
2 minutes ago

I found you a Death Cross on the daily chart of AS3.F.

AS3.F Daily Candlestick Chart
BCOR.PSE
4 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of BCOR.PSE.

BCOR.PSE Daily Candlestick Chart
ADS1.F
5 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ADS1.F.

ADS1.F Daily Candlestick Chart
ADS.F
5 minutes ago

I found you a Three White Soldiers Candle Pattern on the daily chart of ADS.F.

ADS.F Daily Candlestick Chart
8NI.F
8 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of 8NI.F.

8NI.F Daily Candlestick Chart
6LLN.F
13 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of 6LLN.F.

6LLN.F Daily Candlestick Chart
4R6.F
17 minutes ago

I found you a Three White Soldiers Candle Pattern on the daily chart of 4R6.F.

4R6.F Daily Candlestick Chart
ASHIKA.BSE
21 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ASHIKA.BSE.

ASHIKA.BSE Daily Candlestick Chart
PXH.F
22 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of PXH.F.

PXH.F Daily Candlestick Chart
PNE3.F
24 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of PNE3.F.

PNE3.F Daily Candlestick Chart
NTG.F
28 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of NTG.F.

NTG.F Daily Candlestick Chart
NEN.F
30 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of NEN.F.

NEN.F Daily Candlestick Chart
NCGB.F
30 minutes ago

I found you a Three White Soldiers Candle Pattern on the daily chart of NCGB.F.

NCGB.F Daily Candlestick Chart
MSBA.F
34 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MSBA.F.

MSBA.F Daily Candlestick Chart
M4M.F
35 minutes ago

I found you a Three White Soldiers Candle Pattern on the daily chart of M4M.F.

M4M.F Daily Candlestick Chart
LM06.F
37 minutes ago

I found you a RSI Bullish Reversal Divergence on the daily chart of LM06.F.

LM06.F Daily Candlestick Chart
LF9.F
38 minutes ago

I found you a MACD Bearish Reversal Divergence on the daily chart of LF9.F.

LF9.F Daily Candlestick Chart
LDE.F
38 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of LDE.F.

LDE.F Daily Candlestick Chart
IV8.F
42 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of IV8.F.

IV8.F Daily Candlestick Chart
IJCA.F
43 minutes ago

I found you a RSI Bullish Reversal Divergence on the daily chart of IJCA.F.

IJCA.F Daily Candlestick Chart
CDOU.XETRA
43 minutes ago

I found you a Golden Cross on the daily chart of CDOU.XETRA.

CDOU.XETRA Daily Candlestick Chart